FDA Inspection 1153385 — Wilmington Reproductive Laboratories
The FDA completed an inspection of Wilmington Reproductive Laboratories on August 26, 2021 in Wilmington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 26, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wilmington, NC (United States)